相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase
Hao Jiang et al.
ANNALS OF HEMATOLOGY (2011)
Poor outcome after reintroduction of imatinib in patients with chronic myeloid leukemia who interrupt therapy on account of pregnancy without having achieved an optimal response
Aya Kuwabara et al.
BLOOD (2010)
Optimizing Therapy for Patients With Chronic Myelogenous Leukemia in Chronic Phase
Hagop M. Kantarjian et al.
CANCER (2010)
Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study
Lucien Noens et al.
BLOOD (2009)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, Philadelphia-positive chronic myeloid leukemia: The GIMEMA working party on CML
Francesca Palandri et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country
Senthil Rajappa et al.
LEUKEMIA & LYMPHOMA (2008)
Treatment of chronic myeloid leukemia in the imatinib era - Perspective from a developing country
Zeba Aziz et al.
CANCER (2007)
Treatment interruptions and non-adherence with imatinib and associated healthcare costs - A retrospective analysis among managed care patients with chronic myelogenous leukaemia
Theodore Darkow et al.
PHARMACOECONOMICS (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
Michele Baccarani et al.
BLOOD (2006)
分享论文
